-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Key Advantages of Mouse-Derived Immune System Models
Author:
InnoModels
Release time:
2024-04-08
In the field of biomedical research, immune system models have always been an important tool for researchers. In recent years, with its unique advantages, the murine immune system model of InnoModels Biotechnology has gradually emerged as an important tool for researchers, providing powerful support for the study of many diseases. In this article, we will introduce the main advantages of InnoModels' murine immune system model and discuss its application prospects in biomedical research.
1、Highly simulate the human immune system
The mouse-derived immune system model of InnoModels uses gene editing technology to introduce genes related to the human immune system into the mouse genome, thus realizing the goal of constructing a highly simulated human immune system in the mouse. This model can simulate the complexity and diversity of the human immune system, providing a more realistic experimental environment for the study of disease occurrence, development and treatment.
2. Highly controllable
Compared with the traditional immune system model, InnoModels' murine immune system model is more controllable. Researchers can precisely control gene editing to achieve targeted regulation of specific components of the immune system, signaling pathways or disease models. This highly controllable feature makes the research process more precise and reliable, and is conducive to revealing the essential laws of the immune system.

3、Easy to operate and reproduce
As a commonly used experimental animal, rodents are easy to raise, reproduce quickly and operate easily. InnoModels Biotechnology rodent immune system model inherits these advantages, which enables researchers to obtain a large number of experimental animals in a short period of time, accelerating the research process. In addition, the in-depth study of the rodent genome also provides researchers with abundant genetic resources and tools to facilitate various experimental operations.
4. Prospects for wide application
The model of murine immune system has a broad application prospect in the field of biomedical research. First, the model can be used to study the pathogenesis of immune-related diseases, such as autoimmune diseases, infectious diseases and tumors. By simulating the pathological process of human immune system, it helps to discover new therapeutic targets and methods. Second, the model can be used for drug screening and evaluation. Researchers can use the model to evaluate the efficacy and safety of drug candidates, providing strong support for new drug development. Finally, the model can also be used to study the normal physiological functions of the immune system, providing a powerful tool to reveal the mysteries of the immune system.
In conclusion, with its advantages of highly simulating the human immune system, controllability, ease of manipulation and reproduction, as well as the prospect of wide application, the InnoModels Biotechnology murine immune system model has demonstrated great potential and value in the field of biomedical research. With the continuous development and improvement of the technology, it is believed that this model will bring broader application prospects for disease research, drug development and immunotherapy.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd